The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| MIR | -50% | -79.69% | -27.27% | -99% |
| S&P | +13.95% | +78.35% | +12.25% | +398% |
MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. Its tests provide hospitals, labs, clinics, and individuals with rapid diagnosis for diseases, including human immunodeficiency virus and hepatitis C. It offers its tests under the Reveala, Multiplo, and Miriad brands. The company was founded by Hermes Hermes Chan and Carlina Hui in 1993 and is headquartered in Halifax, Canada.
No news articles found for MedMira.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $54.21K | -12.2% |
| Gross Profit | -$216.68K | 17.1% |
| Gross Margin | -399.71% | 23.8% |
| Market Cap | $55.81M | -3.2% |
| Net Income | -$813.13K | 37.5% |
| EBITDA | -$405.96K | 55.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $0.00K | -100.0% |
| Accounts Receivable | $1.33M | -1.8% |
| Inventory | 0.2 | 10.6% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.46M | -17.3% |
| Short Term Debt | $14.61M | 16.2% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -94.02% | -13.7% |
| Return On Invested Capital | 16.82% | 1.5% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$254.98K | 74.5% |
| Operating Free Cash Flow | -$254.98K | 74.4% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -4.87 | -3.23 | -2.59 | -2.59 | -21.65% |
| Price to Sales | 340.34 | 260.63 | 232.06 | 239.55 | 47.45% |
| Price to Tangible Book Value | -4.87 | -3.23 | -2.59 | -2.59 | -21.65% |
| Enterprise Value to EBITDA | -119.86 | -122.28 | -125.91 | -179.55 | 127.69% |
| Total Debt | $15.59M | $16.20M | $16.75M | $17.07M | 9.78% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
